Target intelligence / Profile preview

Cytochrome P450 family 27 subfamily B member 1 (CYP27B1)

Target
CYP27B1
Molecular classification
Enzyme, Oxidoreductase, Cytochrome P450 monooxygenase
01

Overview

Cytochrome P450 family 27 subfamily B member 1 (CYP27B1) is a mitochondrial cytochrome P450 monooxygenase enzyme that catalyzes the conversion of calcifediol to calcitriol, the hormonally active form of vitamin D. This reaction is the rate-limiting step in the activation of vitamin D, which is essential for the regulation of calcium and phosphate homeostasis and thus for bone health. The enzyme is predominantly expressed in the proximal renal tubule but also found in other tissues, including bone, immune cells, and skin. Loss-of-function mutations lead to vitamin D-dependent rickets type IA, underscoring its critical role in endocrine and mineral metabolism.

Other names
25-Hydroxyvitamin D 1-alpha-hydroxylase25-Hydroxyvitamin D3 1-alpha-hydroxylaseCalcidiol 1-monooxygenase1-alpha-hydroxylaseVDDR I (Vitamin D-dependent rickets type I protein)Cytochrome P450 27B1
02

Mechanism of action

Hydroxylation of 25-hydroxyvitamin D3 (calcifediol) to the active form 1,25-dihydroxyvitamin D3 (calcitriol) Mitochondrial monooxygenase activity dependent on adrenodoxin as an electron transfer partner

03

Biological functions

Vitamin D metabolism (hydroxylation of calcifediol to calcitriol)Regulation of calcium homeostasisRegulation of phosphate homeostasis
04

Disease associations

Vitamin D-dependent rickets type IA (loss-of-function mutations cause this disease)Bone disorders related to vitamin D metabolism abnormalitiesPossible roles in other metabolic bone disease
05

Safety considerations

Mutations in CYP27B1 may result in severe hypocalcemia and bone deformities if untreatedDisruption leads to impaired calcium and phosphate metabolism
06

Interacting drugs

Vitamin D analogs (e.g., calcifediol, calcitriol, alfacalcidol; these are substrates or products rather than direct inhibitors/antagonists)

1 more in the full profile.

07

Biomarkers

Serum 1,25-dihydroxyvitamin D3 concentration (indicator of enzyme activity)Genetic variants/mutations in CYP27B1 gene (for Vitamin D-dependent rickets type IA diagnosis)

Beyond the preview

Go deeper on Cytochrome P450 family 27 subfamily B member 1 (CYP27B1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 family 27 subfamily B member 1 (CYP27B1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call